Drug intelligence / Profile preview

alfacalcidol

Development stage
Phase 4
Lead developer
LEO Pharma
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Alfacalcidol is a synthetic analogue of vitamin D used primarily to manage hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure. It is also indicated for the treatment of various forms of rickets and osteomalacia, including nutritional, malabsorptive, vitamin D-dependent, and hypophosphataemic types. Alfacalcidol works by increasing serum calcium levels through stimulation of intestinal calcium absorption, reabsorption from bone, and possibly renal reabsorption. It also modestly increases intestinal phosphorus absorption and suppresses parathyroid hormone (PTH) secretion. These actions help maintain proper calcium balance essential for bone health[1][3][4][5].

Brand names
One-AlphaSANDOZ AlfacalcidolBoneOne
Other names
1-Hydroxycholecalciferol
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on alfacalcidol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alfacalcidol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call